<?xml version="1.0" encoding="UTF-8"?><html xmlns="http://www.w3.org/1999/xhtml" xmlns:oboInOwl="http://www.geneontology.org/formats/oboInOwl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:obo="http://purl.obolibrary.org/obo/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:dublincorens="http://purl.org/dc/elements/1.1/"  version="XHTML+RDFa 1.0" ><body> <br />           Cdk-Activating Kinase Cak1p Promotes Meiotic S Phase <br />                                Ime2p <br />  <br />  <br />              CAK1 encodes essential protein kinase Saccharomyces cerevisiae required activation           Cdc28p Cdk. CAK1 CDC28-independent functions unique meiosis. earliest           functions induce S phase, regulated differently meiosis mitosis. mitosis, <br />           Cdc28p controls S-phase-promoting activity signaling destruction inhibitor, Sic1p.           meiosis, Sic1p destruction signaled meiosis-specific Ime2p protein kinase. data Cak1p <br />           required activate Ime2p mechanism requires threonine 242 tyrosine 244 Ime2p&#226;&#8364;&#8482;s <br />           activation loop. activation promotes autophosphorylation accumulation multiply phosphorylated <br />           forms Ime2p meiotic development. Consistent Cak1p&#226;&#8364;&#8482;s role activating Ime2p, cells lacking <br />           Cak1p deficient degrading Sic1p. Deletion SIC1 overexpression IME2 partially suppress           S-phase defect cak1 mutant cells, suggesting Ime2p key target Cak1p regulation. data           Cak1p required destruction Sic1p meiosis, mitosis, meiosis, functions           sporulation-specific kinase. <br />  <br />  <br />    Meiosis pathway used sexually reproducing organ-                 transcriptionally induced specific times sporulation <br /> isms produce haploid gametes. yeast Saccharomyces                   (25). subset kinases regulate transcriptional <br /> cerevisiae, mitotically growing diploid cells undergo sporula-                program feedback loops, required tion, highly regulated program meiotic development,                 regulate execution specific landmark events. <br /> starved key nutrients (18). Successful sporulation depends                    progression mitotic meiotic cell division ordered execution landmark events. induction,                 pathways eukaryotic organisms requires changes cells undergo single round DNA synthesis (meiotic S                      activities cyclin-dependent kinases (Cdks)  <br /> phase) followed high levels homologous recombination.                   trolled phosphorylation binding inhibitors  cells complete rounds chromosomal segregation                    cyclin activators. activation, Cdks need phos- intervening round DNA synthesis. resulting                  phorylated activation loops (T-loops) Cdk-activat- <br /> haploid products engulfed prospore membrane                    ing kinases (CAKs) (16, 32). S. cerevisiae, sole essential <br /> subsequently surrounded multilayered spore wall                  Cdk required drive mitotic cell cycle, Cdc28p, acti- <br /> capable protecting cell variety environmental                vated phosphorylation threonine 169 monomeric <br /> insults. Coordination landmark events sporulation                Cak1p enzyme (7, 14, 36). essential role Cak1p key ensuring genetic diversity proper chromosome num-                  mitosis activate Cdc28p, shown observation ber.                                                                          Cak1p dispensable cells harboring allele CDC28 <br />    level regulation sporulation program occurs                  (CDC28-43244), contains acidic substitution T169 transcriptional cascade (20). Genome-wide tran-                   additional activating point mutations (5). Cdk ho- <br /> scriptional analysis shown 1,600                   mologs, Bur1p Kin28p, phosphorylated Cak1p <br /> 6,000 genes yeast exhibit transcriptional regulation                conserved threonine (T240 T162, respectively), sporulation (3, 25). genes temporally classi-                 phosphorylation essential cell division fied 12 subgroups.  broadly refer timing              standard conditions (17, 41). Cak1p appears largely  gene induction early, middle, late. way                 regulated mitosis (15). contrast, meiotic  <br /> cell regulates events sporulation networks                   velopment, CAK1 transcriptionally induced middle <br /> protein kinases. 120 protein kinase homologs                   sporulation gene. previously identified CAK1 multi- <br /> yeast function program. Thirty kinases                                                                               copy suppressor mutants SMK1, encodes mito- <br />                                                                               gen-activated protein kinase (MAPK) required spore wall <br />    * Corresponding author. Mailing address: Department Biochem- <br />                                                                               morphogenesis (38). studies using CAK1-indepen- <br /> istry Molecular Pharmacology, Thomas Jefferson University, Phil-          dent allele CDC28 (CDC28-43244) revealed Cak1p <br /> adelphia, PA 19107. Phone: (215) 503-4139. Fax: (215) 923-9162. E-            functions CDC28-independent manner mail: winter@lac.jci.tju.edu.                                                 steps sporulation (27). Cak1p required timely <br />    &#226;&#8364;&#160; paper dedicated memory Ira Herskowitz   <br /> ceased 28 April 2003). <br />                                                                               progression meiotic S phase later required <br />    &#226;&#8364;&#161; Present address: Molecular Sciences Institute, Berkeley, CA              spore wall formation SMK1 MAPK pathway. <br /> 94704.                                                                        Cdc28p required execution meiotic S phase  <br />                                                                        8718 <br />  VOL. 23, 2003                                                                                                                            CAK1 IME2               8719 <br />  <br />  meiotic divisions, raising possibility Cak1p                        ated step amplification overlapping PCR fragments generate regulate steps CDC28-dependent fashion (1,                             chimeric construct containing 483 bp 5&#226;&#172;&#732; SIC1 initiator ATG, 1-kb URA3 <br />                                                                                        marker cassette, 678 bp GAL1 promoter, 415 bp SIC1 open <br /> 29).  Cak1p appears play central role regulating                          reading frame. step, URA3::GAL1-SIC1 fragment generated <br /> multiple steps meiosis multiple substrates.                                 PCR amplification pMDM169 (22). second step, upstream <br />    IME2 encodes meiosis-specific kinase promotes mei-                           region SIC1 amplified S288C genomic DNA, yielding product <br /> otic S M phases (9, 21, 31). Similar cak1-&#226;&#338;&#172; pheno-                          containing 21 bp 3&#226;&#172;&#732; homology URA3. PCR products                                                                                        mixed final reaction amplified using outermost primers <br /> type, cells lacking IME2 fail perform timely efficient <br />                                                                                        described  final 2.6-kb PCR product used transform meiotic S phase. Ime2p thought stimulate S phase                              cak1-&#226;&#338;&#172;::TRP1/CAK1 CDC28-43244/CDC28-43244 strain. Transformants growing <br /> promoting degradation Cdk inhibitor Sic1p (6).                              SD medium lacking <span id='am-61' about='obo:IMR_0200234' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001998'><span id='am-62' property="oboInOwl:id" content="IMR:0200234" datatype="xsd:string"></span><span id='am-63' property="oboInOwl:hasDbXref" content="KEGG:C00106" datatype="xsd:string"></span><span id='am-64' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-65' property="rdfs:label" content="Uracil" datatype="xsd:string"></span>uracil</span> sporulated, tetrads dissected, seg- <br /> Ime2p enhances transcription early genes                            regants mated construct homozygous diploids galactose-containing <br /> stabilizes transcriptional activator early genes,                           media. Galactose-dependent induction noninduced levels SIC1                                                                                        monitored immunoblotting. <br /> Ime1p, induced (10). Ime2p later respon-                             myc-tagged IME2-T-loop mutants generated site-directed mu- <br /> sible promoting middle gene expression enhancing                            tagenesis (QuikChange kit; Stratagene) IME2 gene pAM4. T242 <br /> production activation middle sporulation gene                               codon changed mutating ACG GCG, Y244 codon (MSG) transcriptional activator, Ndt80p, turn induces                         changed F mutating TAC TTC, Y241 codon changed B-type cyclins (Clbs) required activate Cdc28p,                        F mutating TAT TTT, S246 codon changed                                                                                        mutating AGC GCC. create chromosomally integrated strains, PCR promoting nuclear divisions (1, 2, 11, 34). Ime2p                          products containing IME2 coding information mutant plasmids negatively regulates Sum1p, transcriptional repressor                         150 bp upstream ATG 1,910 bp downstream ATG) middle genes (19, 23, 24, 39).                                                         used transform haploid ime2&#226;&#338;&#172;M::URA3Kl-13Myc::TRP1 strain (KBY443) <br />    cells use machinery carry mitotic                          (1). Loss URA3 selected 5-fluoroorotic acid (5-FOA), integration <br />                                                                                        confirmed diagnostic PCR restriction digestion. Homozygous diploids meiotic S phases, organisms developed meiosis- <br />                                                                                        generated backcrossing FOAR haploids wild-type SK1 haploids specific regulation machinery. example, destruction                         cak1-&#226;&#338;&#172;::TRP1 CDC28-43244 haploids (ALY1125), followed sporulation, tet- Sic1p key step entry mitotic meiotic S                       rad dissection, mating. <br /> phase. Sic1p binds inhibits kinase activity S-                              IME2-myc high-copy-number plasmid (pAM4) generated pMR1 <br /> phase-promoting Cdc28p-Clb5p Cdc28p-Clb6p complexes                                steps.  SmaI restriction site introduced frame just prior <br />                                                                                        stop codon IME2 (QuikChange kit; Stratagene).  myc tag (28). mitotically growing cells ready initiate DNA                         PCR amplified KSY137 genomic DNA 3&#226;&#172;&#732; primer introduced synthesis, G1 cyclin-Cdc28p complex phosphorylates Sic1p,                          KpnI restriction site. Finally, myc PCR fragment ligated plasmid <br /> targeting ubiquitin-mediated proteolysis, liberating                       cut SmaI KpnI. <span id='am-34' about='obo:IMR_0001349' typeof='owl:Thing obo:IMR_0001657 obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001698'><span id='am-35' property="oboInOwl:id" content="IMR:0001349" datatype="xsd:string"></span><span id='am-36' property="obo:IAO_0000115" content="A nucleotide consists of a nitrogen-containing base, a five-carbon sugar, and one or more phosphate groups. Nucleotides can carry chemical energy (e.g. ATP), form coenzymes (e.g. CoA), be used as specific signaling molecules (e.g. cAMP) in the cell. Nucleotides are the subunits of the nucleic acids. " datatype="xsd:string"></span><span id='am-37' property="rdfs:label" content="nucleoside phosphate" datatype="xsd:string"></span><span id='am-38' property="rdfs:label" content="nucleotide" datatype="xsd:string"></span><span id='am-39' property="oboInOwl:hasDbXref" content="CHEBI:25608" datatype="xsd:string"></span><span id='am-40' property="oboInOwl:hasExactSynonym" content="nucleoside phosphate" datatype="xsd:string"></span><span id='am-41' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span>nucleotide</span> sequences mutant <br /> Cdc28p-Clb5p/6p trigger S phase (37). Recent data                              derivatives plasmid determined. <br />                                                                                           Growth sporulation cells. Vegetative growth maintained YEPD <br /> shown Cdc28p required meiotic S phase, consistent <br />                                                                                        (1% yeast extract, 2% peptone, 2% glucose), SD (0.67% yeast nitrogen base dependence meiotic S phase Clb5p Clb6p                              amino acids 2% glucose plus nutrients essential auxotrophic <br /> (1, 35). meiosis  Cdc28p dispensable Sic1p                           strains), YEPA (1% yeast extract, 2% peptone, 2% potassium acetate). degradation (1). Instead, Sic1p destruction meiosis requires                        synchronous sporulation, cells grown YEPA optical density 600 <br /> Ime2p (6). CDC28-43244 able bypass requirement                           nm (OD600) 0.3 0.5. Cells harboring galactose-inducible allele SIC1 <br />                                                                                        pregrown media described containing galactose instead CAK1 mitotic S phase meiotic S phase, suggesting                         glucose, harvested, washed water, grown YEPA 4 generations. Prior Cak1p controls activity meiosis-specific regulator                       sporulation, cells harvested, washed SM (2% potassium acetate plus S phase CDC28-independent manner (27).                                 10 &#226;&#65533;&#174;g <span id='am-18' about='obo:IMR_0200350' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001998'><span id='am-19' property="oboInOwl:hasDbXref" content="KEGG:C00147" datatype="xsd:string"></span><span id='am-20' property="rdfs:label" content="Adenine" datatype="xsd:string"></span><span id='am-21' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-22' property="oboInOwl:id" content="IMR:0200350" datatype="xsd:string"></span>adenine</span>, 5 &#226;&#65533;&#174;g histidine, 30 &#226;&#65533;&#174;g leucine, 7.5 &#226;&#65533;&#174;g lysine, 10 &#226;&#65533;&#174;g examined CDC28-independent roles Cak1p                               tryptophan, 5 &#226;&#65533;&#174;g uracil ml) resuspended SM 2 OD units/ml.                                                                                        experiments shown Fig. 3 4, cells grown YEPA OD600 <br /> promoting meiotic S phase. <br />                                                                                        1.5 3.0 prior sporulation 1.5 OD unit/ml 1% potassium acetate plus <br />    strains lacking CAK1 deficient                        0.02% raffinose. <br /> timing Sic1p degradation. Removal SIC1 genetic                              vitro kinase assay. kinase activity Ime2p-myc measured background partially suppresses meiotic S-phase defect,                            described Benjamin et al. (1). Briefly, sporulating cells harvested suggesting essential early CDC28-independent role                          frozen liquid nitrogen various times postinduction.  cells lysed <br />                                                                                        3 cycles 1-min bursts bead beating followed 2 min ice (500 &#226;&#65533;&#174;l Cak1p promote Sic1p degradation. role likely                                                                                        0.5-mm-diameter glass beads; BioSpec Products) 500 &#226;&#65533;&#174;l lysis buffer (50 mM <br /> operate Ime2p, overexpression IME2                               HEPES [pH 7.4], 75 mM KCl, 1 mM EGTA, 1 mM MgCl2, 0.1% NP-40, 50 mM <br /> partially suppress S-phase delay cak1-&#226;&#338;&#172; mutants.                          NaF, 50 mM &#226;&#65533;&#164;-glycerolphosphate, 1 mM Na3VO4, 1 mM phenylmethylsulfonyl <br /> Ime2p phosphorylated catalytically active cells                       fluoride, 8.8 &#226;&#65533;&#174;g aprotinin ml, 4 &#226;&#65533;&#174;g antipain ml, 0.1 &#226;&#65533;&#174;g pefabloc <br /> taining CAK1, phosphorylated catalytically                         SC ml, 2 &#226;&#65533;&#174;g pepstatin ml, 1 &#226;&#65533;&#174;g chymostatin ml, 1 mM <br />                                                                                        benzamidine, 2 &#226;&#65533;&#174;g leupeptin ml). Equal amounts protein (2 6 mg) <br /> active cells lacking CAK1. Mutational analyses IME2                              clarified supernatants used immunoprecipitation Ime2p-myc <br /> indicate Cak1p-dependent activation Ime2p                               20 &#226;&#65533;&#174;l 1:1 slurry 9E10 beads (Covance) mixing 1.5 h. Immu- <br /> quires threonine residue tyrosine residue located                       noprecipitates collected washed times lysis buffer presumed activation loop Ime2p. data suggest                             kinase buffer (20 mM HEPES [pH 7.4], 100 mM KCl, 10 mM MgCl2).                                                                                        immunoprecipitate removed Western blotting, remainder <br /> Cak1p promotes meiotic S phase stimulating phosphor- <br />                                                                                        resuspended 25 &#226;&#65533;&#174;l kinase buffer plus 5 &#226;&#65533;&#174;Ci [&#226;&#65533;&#165;-32P]<span id='am-23' about='obo:IMR_0001351' typeof='owl:Thing obo:IMR_0000967 obo:IMR_0001657 obo:IMR_0000947 obo:IMR_0000965 obo:IMR_0001349 obo:IMR_0000001 obo:IMR_0001698'><span id='am-24' property="oboInOwl:hasExactSynonym" content="adenosine triphosphate" datatype="xsd:string"></span><span id='am-25' property="rdfs:label" content="adenosine 5&apos;-triphosphate" datatype="xsd:string"></span><span id='am-26' property="oboInOwl:hasAlternativeId" content="IMR:0200394" datatype="xsd:string"></span><span id='am-27' property="rdfs:label" content="adenosine triphosphate" datatype="xsd:string"></span><span id='am-28' property="oboInOwl:hasAlternativeId" content="IMR:0100127" datatype="xsd:string"></span><span id='am-29' property="oboInOwl:hasDbXref" content="KEGG:C00002" datatype="xsd:string"></span><span id='am-30' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-31' property="oboInOwl:id" content="IMR:0001351" datatype="xsd:string"></span><span id='am-32' property="rdfs:label" content="ATP" datatype="xsd:string"></span><span id='am-33' property="oboInOwl:hasExactSynonym" content="adenosine 5&apos;-triphosphate" datatype="xsd:string"></span>ATP</span> (Amersham), <br /> ylation activation Ime2p meiosis-specific protein                           10 &#226;&#65533;&#174;M ATP, 10 &#226;&#65533;&#174;g purified MBP-Ndt80p substrate. reactions kinase.                                                                                terminated 30-min incubation 30&#194;&#176;C addition sodium dodecyl <br />                                                                                        sulfate-containing gel loading buffer followed boiling. Samples resolved <br />                                                                                        12% polyacrylamide gels prior audoradiography. <br />                          MATERIALS METHODS <br />                                                                                           DNA staining analysis. monitor meiotic divisions, 2 OD units   Yeast strains plasmids. yeast strains plasmids used study        sporulating cells taken various times, fixed 90% ethanol (EtOH), described Tables 1 2, respectively. strains used study   stained 1 &#226;&#65533;&#174;g 4&#226;&#172;&#732;,6-diamidino-2-phenylindole (DAPI) ml. comple- SK1 genetic background. galactose-inducible allele SIC1 gener-          tion meiotic divisions scored counting proportion cells <br />  8720       SCHINDLER ET AL.                                                                                                                              MOL. CELL. BIOL. <br />  <br />  <br />                                                             TABLE 1. Yeast strains used study <br />                                                                                                                                                                   Source  Strain                                                                       Genotype <br />                                                                                                                                                                   reference <br />  <br /> LNY3                      MATa/MAT&#226;&#65533;&#163; ura3/ura3 leu2::hisG/leu2::hisG trp1::hisG/trp1::hisG lys2/lys2                                                          L. Neigeborne <br />                             ho::LYS2/ho::LYS2 <br /> LNY65                     MATa/MAT&#226;&#65533;&#163; ime2::LEU2/ime2::LEU2 ura3/ura3 leu2::hisG/leu2::hisG trp1::hisG/trp1::hisG                                              L. Neigeborne <br />                             lys2/lys2 ho::LYS2/ho::LYS2 <br /> JLY3                      MATa/MAT&#226;&#65533;&#163; ura3/ura3 leu2::hisG/leu2::hisG trp1::hisG/trp1::hisG lys2/lys2                                                          27 <br />                             ho::LYS2/ho::LYS2 CDC28-43244/CDC28-43244 <br /> JLY4                      MATa/MAT&#226;&#65533;&#163; ura3/ura3 leu2::hisG/leu2::hisG trp1::hisG/trp1::hisG lys2/lys2                                                          27 <br />                             ho::LYS2/ho::LYS2 CDC28-43244/CDC28-43244 cak1-&#226;&#338;&#172;::TRP1/cak1-&#226;&#338;&#172;::TRP1 <br /> KSY111                    JLY4 &#226;&#171;&#185; GAL1-SIC1::URA3/GAL1-SIC1::URA3                                                                                             study <br /> KSY112                    JLY3 &#226;&#171;&#185; GAL1-SlC1::URA3/GAL1-SlC1::URA3                                                                                             study <br /> KSY137                    MATa/MAT&#226;&#65533;&#163; ura3/ura3 leu2::hisG/leu2::hisG trp1-&#226;&#338;&#172;FA::hisG trp1::hisG/trp1-&#226;&#338;&#172;FA::hisG                                           study <br />                             trp1::hisG lys2/lys2 ho::hisG ho::LYS2/ho::hisG ho::LYS2 <br />                             IME2-myc::TRP1/IME2-myc::TRP1 CDC28-43244/CDC28-43244 <br /> KSY138                    MATa/MAT&#226;&#65533;&#163; ura3/ura3 leu2::hisG/leu2::hisG trp1-&#226;&#338;&#172;FA::hisG trp1::hisG/trp1-&#226;&#338;&#172;FA::hisG                                           study <br />                             trp1::hisG lys2/lys2 ho::hisG ho::LYS2/ho::hisG ho::LYS2 <br />                             IME2-myc::TRP1/IME2-myc::TRP1 CDC28-43244/CDC28-43244 <br />                             cak1-&#226;&#338;&#172;::TRP1/cak1-&#226;&#338;&#172;::TRP1 <br /> KSY189                    KSY137 &#226;&#171;&#185; ime2-K97R-myc::TRP1/ime2-K97R-myc::TRP1                                                                                     study <br /> KSY220                    KSY137 &#226;&#171;&#185; ime2-T242A, Y244F-myc::TRP1/ime2-T242A, Y244F-myc::TRP1                                                                     study <br /> KSY222                    KSY137 &#226;&#171;&#185; ime2-Y244F-myc::TRP1/ime2-Y244F-myc::TRP1                                                                                   study <br /> KSY190                    KSY138 &#226;&#171;&#185; ime2-K97R-myc::TRP1/ime2-K97R-myc::TRP1                                                                                     study <br /> KSY218                    KSY138 &#226;&#171;&#185; ime2-T242A, Y244F-myc::TRP1/ime2-T242A, Y244F-myc::TRP1                                                                     study <br /> KSY219                    KSY138 &#226;&#171;&#185; ime2-Y244F-myc::TRP1/ime2-Y244F-myc::TRP1                                                                                   study <br /> KSY223                    KSY138 &#226;&#171;&#185; ime2-T242A-myc::TRP1/ime2-T242A-myc::TRP1                                                                                   study <br /> AMY22                     LNY65 &#226;&#171;&#185; pAM4                                                                                                                         study <br /> AMY23                     LNY65 &#226;&#171;&#185; pSM1                                                                                                                         study <br /> AMY24                     LNY65 &#226;&#171;&#185; pSM2                                                                                                                         study <br /> AMY25                     LNY65 &#226;&#171;&#185; pSM3                                                                                                                         study <br /> AMY28                     LNY65 &#226;&#171;&#185; pSM6                                                                                                                         study <br /> AMY34                     LNY65 &#226;&#171;&#185; pSM10                                                                                                                        study <br />  <br />  <br />  <br /> containing DAPI-staining body observed fluorescence micros-             Cdc28p 7.5% gel analyze Ime2p, run 20 25 mV, transferred <br /> copy. cells independent isolates strain           Immobilon-P membrane (Millipore), blocked overnight 4&#194;&#176;C mix- <br /> analyzed. measure DNA content, 3 OD units sporulating cells fixed           ture containing phosphate-buffered saline (PBS) 0.1% Tween 20 plus  <br /> 70% EtOH various time points. Prior analysis, 1 OD unit cells               Block (Tropix). Antibody staining performed 1 h room temperature <br /> digested 1 mg RNase ml 5 mg pepsin ml staining           polyclonal antibodies Sic1p (1:5,000; gift M. Tyers), Ime2p <br /> overnight 4&#194;&#176;C 0.5 mg propidium iodide ml. Cells diluted         (30), Cdc28p (1:1,000) (33), T-169PO4-Cdc28p (1:100) (26). washing, <br /> 1:5, lightly sonicated reduce clumping, analyzed Beckman-Coulter           membrane incubated 1 h room temperature secondary <br /> XL cell sorter. Analysis conducted times strain.                    anti-rabbit antibody (Promega, 1:5,000; Covance, 1:1,000). myc epitope <br />    Immunological analysis proteins. cell lysates prepared            Ime2p detected 9E10 monoclonal antibody (Santa Cruz, 1:1,000; <br /> scribed Yaffe Schatz (40). Briefly, 2 4 OD units sporulating cells      Covance, 1:2,000) secondary anti-mouse antibody (Promega, 1:5,000; harvested various times washed resuspended 1 ml             Amersham, 1:2,000). Detection secondary antibody achieved ice-cold water plus 25 mM &#226;&#65533;&#164;-glycerolphosphate, 1 mM Na3VO4, 100 &#226;&#65533;&#174;g                chemiluminescence (Tropix <span id='am-13' about='obo:IMR_0200468' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001998'><span id='am-14' property="oboInOwl:hasDbXref" content="KEGG:C00112" datatype="xsd:string"></span><span id='am-15' property="oboInOwl:id" content="IMR:0200468" datatype="xsd:string"></span><span id='am-16' property="rdfs:label" content="CDP" datatype="xsd:string"></span><span id='am-17' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span>CDP</span>-Star Amersham ECL enhanced chemi- phenylmethylsulfonyl fluoride ml. addition 150 &#226;&#65533;&#174;l ice-cold 2 M        luminescence . <br /> NaOH 8% &#226;&#65533;&#164;-mercaptoethanol, samples stored &#226;&#171;&#186;80&#194;&#176;C. Samples                   epitope-tagged Ime2p shown Fig. 5 partially purified freezing <br /> thawed ice, proteins precipitated addition 150 &#226;&#65533;&#174;l 50%               grinding cells liquid N2 prior lysis buffer described  vitro <br /> trichloroacetic acid, incubation 10 min 4&#194;&#176;C, centrifugation 2 min.        kinase assay&#226;&#8364;&#65533; section  Tris-Cl substituted HEPES) clarifica- <br /> Pellets washed twice cold acetone, briefly dried vacuum, resuspended        tion centrifugation. clarified lysate loaded Q-Sepharose column 300 &#226;&#65533;&#174;l 3&#226;&#171;&#187; sample buffer, boiled 3 min. Samples diluted 1:2         (Amersham), washed lysis buffer, eluted step gradient Laemmli sample buffer loaded 10% polyacrylamide gel analyze Sic1p            increasing KCl concentration (0.2 M increments). Ime2p-myc eluted                                                                                          beads 0.4 M KCl. <br />  <br />  <br />                   TABLE 2. Plasmids used study <br />                                                                                                                              RESULTS <br />                                                                     Source Plasmid                         Markers <br />                                                                     reference <br />                                                                                             CAK1 mutants deficient timing Sic1p degrada- <br /> YEp351          2&#226;&#65533;&#174;m LEU2                                       12                        tion. mitosis, essential function CAK1 pS324           2&#226;&#65533;&#174;m LEU2 YEp13 &#226;&#171;&#185; IME2                          Saul   Honigberg          bypassed CAK1-independent allele CDC28 (CDC28- <br /> pMR1            2&#226;&#65533;&#174;m URA3 pRS426 &#226;&#171;&#185; IME2                         27 <br />                                                                                          43244) contains <span id='am-49' about='obo:IMR_0100119' typeof='owl:Thing obo:IMR_0000967 obo:IMR_0000947 obo:IMR_0000965 obo:IMR_0001695 obo:IMR_0000001 obo:IMR_0100116'><span id='am-50' property="rdfs:label" content="L-Glutamic acid" datatype="xsd:string"></span><span id='am-51' property="oboInOwl:hasDbXref" content="KEGG:C00025" datatype="xsd:string"></span><span id='am-52' property="rdfs:label" content="L-Glutamate" datatype="xsd:string"></span><span id='am-53' property="oboInOwl:hasExactSynonym" content="L-Glutaminic acid" datatype="xsd:string"></span><span id='am-54' property="rdfs:label" content="L-Glutaminic acid" datatype="xsd:string"></span><span id='am-55' property="oboInOwl:hasExactSynonym" content="L-Glutamate" datatype="xsd:string"></span><span id='am-56' property="oboInOwl:id" content="IMR:0100119" datatype="xsd:string"></span><span id='am-57' property="oboInOwl:hasExactSynonym" content="L-Glutamic acid" datatype="xsd:string"></span><span id='am-58' property="oboInOwl:hasAlternativeId" content="IMR:0200156" datatype="xsd:string"></span><span id='am-59' property="rdfs:label" content="glutamic acid" datatype="xsd:string"></span><span id='am-60' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span>glutamic acid</span> place threonine <br /> pAM4            pMR1 &#226;&#171;&#185; 13myc                                     study <br /> pSM1            pAM4 &#226;&#171;&#185; ime2-Y244F-myc                            study              normally phosphorylated Cak1p additional <br /> pSM2            pAM4 &#226;&#171;&#185; ime2-T242A, Y244F-myc                     study              activating point mutations (5). Unless indicated, pSM3            pAM4 &#226;&#171;&#185; ime2-S246A-myc                            study              experiments described report conducted pSM6            pAM4 &#226;&#171;&#185; ime2-Y241F-myc                            study              genetic background. simplicity, CDC28-43244/CDC28- <br /> pSM10           pAM4 &#226;&#171;&#185; ime2-T242A-myc                            study <br />                                                                                          43244 diploid strains containing lacking CAK1  VOL. 23, 2003                                                                                                  CAK1 IME2         8721 <br />  <br />  <br />                                                                          Sic1p-depleted GAL1-SIC1 strains isogenic strains                                                                          expressed SIC1 native control. timing meiotic S <br />                                                                          phase wild-type CAK1 cells containing GAL1-SIC1 allele <br />                                                                          similar wild-type cells containing endogenous <br />                                                                          SIC1 promoter (compare columns 1 2 Fig. 2A).                                                                          contrast, depletion Sic1p cak1-&#226;&#338;&#172;/cak1-&#226;&#338;&#172; background <br />                                                                          advanced entry meiotic S phase (compare columns 3   FIG. 1. Cak1p required timely destruction Sic1p.         4 Fig. 2A). Approximately 50% GAL1-SIC1 cak1-&#226;&#338;&#172; cell lysates CAK1 (JLY3) cak1-&#226;&#338;&#172; (JLY4) homozygous            diploid cells accumulated 4C DNA content 9 h com- <br /> diploid cells CDC28-43244 background prepared         pared 30 h cak1-&#226;&#338;&#172; strain expressing SIC1 indicated times sporulation assayed immunoblot analysis    normal promoter (Fig. 2A), demonstrating failure Sic1p antiserum (&#226;&#65533;&#163;-Sic1). Vegetative growth represented                                                                          cak1-&#226;&#338;&#172; cells efficiently degrade Sic1p account 0-h time point. <br />                                                                          S-phase delay.  depletion Sic1p did                                                                          completely restore timing S phase cak1-&#226;&#338;&#172; cells                                                                          seen wild-type cells 50% cells accumulated 4C <br /> referred wild type  CAK1) cak1-&#226;&#338;&#172;, respec-             DNA content 3 h.  addition promoting Sic1p <br /> tively.                                                                  destruction, Cak1p promote S phase    Wild-type SK1 cells complete meiotic S phase 3 h               additional mechanism. <br /> postinduction standard sporulation conditions                 monitored meiotic divisions Sic1p-depleted <br /> Materials Methods). previously shown cells              (GAL1-SIC1) strains staining cells DAPI various <br /> lacking CAK1 complete meiotic S phase                times sporulation. Wild-type cells initiated meiotic <br /> 24 h postinduction (27). Furthermore, catalytically inactive             divisions 5 6 h postinduction, approximately <br /> cak1 alleles complement S-phase defect, suggesting            80% cells completed divisions 12 h (Fig. 2B). Cak1p phosphotransferase activity required activate           timing meiotic divisions CDC28-43244 strains meiotic S phase. elucidate Cak1p regulates S phase                reproducibly different CDC28 strains (data meiosis, compared Sic1p levels wild-type                shown). Cells lacking CAK1 stalled meiotic pro- <br /> cak1-&#226;&#338;&#172;/cak1-&#226;&#338;&#172; strains. Immunoblotting revealed wild-             gram S phase, nuclear divisions began <br /> type cells, Sic1p levels decreased shortly meiotic induc-          later occurred fewer cells. average, 20% <br /> tion undetectable 4 h postinduction (Fig. 1).           cak1-&#226;&#338;&#172;/cak1-&#226;&#338;&#172; cells completed divisions interval corresponds time meiotic S phase                lengthy incubations (Fig. 2B). population occurred cells. timing decline Sic1p levels       subset cells slowly degraded Sic1p com- similar CDC28 CDC28-43244 cells (data                     pleted S phase 24 48 h postinduction (Fig. 2A, <br /> shown). contrast wild type, Sic1p present high          column 3). Removal Sic1p, using GAL1-SIC1 allele, levels cak1-&#226;&#338;&#172;/cak1-&#226;&#338;&#172; cells, past time wild-type          wild-type CAK1 cells did appear alter timing cells completed S phase, executed meiotic divisions,            meiotic S phase initiation divisions, total initiated spore wall formation (Fig. 1). failure              percentage cells successfully completing meiotic divi- <br /> cak1-&#226;&#338;&#172;/cak1-&#226;&#338;&#172; cells reduce Sic1p protein levels             sions modestly reduced (Fig. 2A B). basis defect Cdc28p activity, Cdc28p dispensable          decrease investigated  Importantly, Sic1p destruction meiosis (1). results suggest         Sic1p depleted cak1-&#226;&#338;&#172;/cak1-&#226;&#338;&#172; background, mei- <br /> Cak1p promotes Sic1p destruction Cdc28p-independent                 otic divisions occurred earlier (Fig. 2B). manner.                                                                  results demonstrate depletion Sic1p partially suppresses <br />    Deletion SIC1 cak1-&#226;&#338;&#172; background partially                defects meiotic S M phases caused deletion passes S-phase delay. primary defect cak1-&#226;&#338;&#172;/               CAK1.  critical early role Cak1p promote <br /> cak1-&#226;&#338;&#172; cells Sic1p degradation, deletion SIC1              decrease Sic1p protein levels relieve inhibition promote progression S phase genetic               Cdc28p activity required S phase. Furthermore, <br /> background. asked deletion SIC1 bypass               data indicate GAL1-SIC1 cak1-&#226;&#338;&#172; diploid mutant S-phase delay observed cak1-&#226;&#338;&#172; mutant strain.           cell carry meiotic divisions meiotic S phase reported sic1-&#226;&#338;&#172; strains genetically unstable           completed. suggests Cak1p CDC28- <br /> prone aneuploidy (22). avoid complication, gen-            independent functions S phase meiotic divi- <br /> erated cak1-&#226;&#338;&#172;/cak1-&#226;&#338;&#172; strain sole source SIC1              sions. <br /> controlled GAL1 promoter (referred GAL1-                  Overexpression IME2 partially bypasses S-phase  <br /> SIC1). GAL1-SIC1 cells grown galactose expressed Sic1p                lay cak1-&#226;&#338;&#172; mutant. Sic1p degradation known  <br /> levels comparable levels Sic1p seen wild-          pend Ime2p meiosis (6). result suggests Cak1p <br /> type cells (data shown). level Sic1p rapidly declined         positively regulate Ime2p. cak1-&#226;&#338;&#172;/cak1-&#226;&#338;&#172; cells fail cells transferred medium containing acetate              produce active Ime2p, introduction additional copies sole carbon source (presporulation medium), Sic1p                IME2 high-copy-number plasmid suppress undetectable sporulation background (Fig.             mutant phenotype. measured meiotic divisions cells <br /> 2C).                                                                     containing 2&#226;&#65533;&#174;m plasmid 2&#226;&#65533;&#174;m plasmid <br />    used flow cytometry (fluorescence-activated cell sorting           containing IME2 24 h sporulation (Table 3). Overex- <br /> [FACS]) compare timing meiotic S phase                  pression IME2 wild-type cells did alter ability  8722       SCHINDLER ET AL.                                                                                                         MOL. CELL. BIOL. <br />  <br />  <br />  <br />  <br />    FIG. 2. Depletion Sic1p partially rescues meiotic S-phase delay cak1-&#226;&#338;&#172; cells. Diploid strains containing galactose-inducible SIC1 <br /> gene allowed depletion Sic1p specifically sporulation.   Progression meiotic S phase monitored flow cytometry detect <br /> cells 2C 4C DNA content indicated  left right: JLY3, KSY112, JLY4, KSY111). Sporulating cells fixed indicated <br /> times postinduction, DNA stained propidium iodide. (B) Completion meiotic divisions monitored fixing cells indicated genotype staining DNA DAPI. Cells viewed microscopy UV light counted completion MI MII. experiments CDC28-43244 genetic background. (C) Protein isolated cak1-&#226;&#338;&#172; strain harboring GAL1-SIC1 <br /> allele (KSY111) grown inducing medium (galactose) noninducing medium (acetate) indicated times transfer sporulation <br /> medium. Sic1p monitored immunoblot analysis. <br />  <br />  <br />  <br /> complete meiosis. cak1-&#226;&#338;&#172;/cak1-&#226;&#338;&#172; cells, pS324 high-copy-                      IME2 plasmid modestly increased percentage cells <br /> number IME2 plasmid increased percentage cells                          completed nuclear divisions 35% 46%. completed nuclear divisions (47% compared 12%).                           genetic interactions suggest cak1-&#226;&#338;&#172; cells  FACS analysis revealed overexpression                             little Ime2p activity decrease Sic1p levels. IME2 advanced timing meiotic S phase cak1-&#226;&#338;&#172;/                          ability high-copy-number IME2 plasmids promote S <br /> cak1-&#226;&#338;&#172; mutant (data shown). Sic1p-depleted GAL1-                         phase cak1-&#226;&#338;&#172;/cak1-&#226;&#338;&#172; strain consistent Cak1p SIC1/GAL-SIC1 cak1-&#226;&#338;&#172;/cak1-&#226;&#338;&#172; cells, high-copy-number                             Ime2p functioning pathway.  ability <br />                                                                                     Sic1p depletion partially bypass S-phase defect                                                                                     cak1-&#226;&#338;&#172;/cak1-&#226;&#338;&#172; mutant consistent Ime2p&#226;&#8364;&#8482;s require- <br /> TABLE 3. Overexpression IME2 partially suppresses meiotic <br />                                                                                     ment execution multiple events early sporulation. <br />                defect cells lacking Cak1pa <br />                                                                                        previously reported overexpression IME2 using <br />                                                              % Meiosis              pRSB733 did effect completion meiotic divisions <br />                 Strain <br />                                                    YEp351                 pS324     cak1-&#226;&#338;&#172;/cak1-&#226;&#338;&#172; mutant (27). pRSB733 contains 270 bp CDC28-43244                                        78 &#226;&#171;&#190; 12               88 &#226;&#171;&#190; 1 <br />                                                                                     promoter sequence, plasmid used (pS324) <br /> cak1-&#226;&#338;&#172; CDC28-43244                                 12 &#226;&#171;&#190; 8                47 &#226;&#171;&#190; 10    contains 1,500 bp promoter. Using IME2 2&#226;&#65533;&#174;m plasmids <br /> GAL1-SIC1 CDC28-43244                              57 &#226;&#171;&#190; 6                59 &#226;&#171;&#190; 3     containing various amounts IME2 promoter sequence, <br /> GAL1-SIC1 cak1-&#226;&#338;&#172; CDC28-                            35 &#226;&#171;&#190; 3                46 &#226;&#171;&#190; 7     correlation length regulatory <br />   43244 <br />                                                                                     region ability suppress S-phase defect cells <br />       indicated homozygous diploid strains harboring high-copy-number           lacking CAK1 (data shown). <br /> vector containing IME2 (pS324) control vector lacking IME2 (Yep351) sporulated 24 h analysis. completion meiotic divisions      Ime2p phosphorylated catalytically inactive determined described Materials Methods.                                   cak1-&#226;&#338;&#172; strain. wanted determine Cak1p  VOL. 23, 2003                                                                                                     CAK1 IME2          8723 <br />  <br />  <br />  <br />  <br />   FIG. 3. Ime2p unmodified cak1-&#226;&#338;&#172; strains. Protein isolated cell lysates sporulating cells indicated times wild-type (W) (KSY137) cak1-&#226;&#338;&#172; (&#226;&#338;&#172;) (KSY138) diploid cells CDC28-43244 genetic background. Ime2p-myc protein assayed immunoblot analysis polyclonal Ime2p antibody. <br />  <br />  <br />  <br /> required normal production phosphorylation                tially purified Ime2p <span id='am-7' about='obo:IMR_0001658' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001'><span id='am-8' property="oboInOwl:hasDbXref" content="CHEBI:24870" datatype="xsd:string"></span><span id='am-9' property="oboInOwl:id" content="IMR:0001658" datatype="xsd:string"></span><span id='am-10' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-11' property="obo:IAO_0000115" content="An atom that has either gained or lost electrons to acquire a chage; for example Na+ and Cl-." datatype="xsd:string"></span><span id='am-12' property="rdfs:label" content="ion" datatype="xsd:string"></span>ion</span>-exchange chromatography  Ime2p. IME2 mRNA expressed specifically meiosis                Materials Methods), allowed better electro- <br /> starting early program continuing             phoretic resolution different phosphorylated forms completion nuclear divisions. Ime2p detected               Ime2p (data shown). <br /> shortly meiotic induction basally phosphorylated                 2 h sporulation medium, Ime2p wild-type cells <br /> form hyperphosphorylated DNA replica-                  migrated doublet (bands 2 3 Fig. 5). tion (1, 34). determine Cak1p required phos-            rapidly migrating member doublet (band 2) appeared phorylation Ime2p, compared Ime2p cells containing              modified, migrated slowly Ime2p lacking CAK1 immunoblot analysis.                                 cells lacking CAK1. Ime2p cak1-&#226;&#338;&#172;/cak1-&#226;&#338;&#172; strain <br />    previously reported, Ime2p present low levels            migrated single band (band 1 Fig. 5). wild-type cells mitotic growth acetate. expression         unable detect heterogeneity Ime2p cak1-&#226;&#338;&#172;/ <br /> level Ime2p 0 h enhanced cells washed             cak1-&#226;&#338;&#172; cells late time points meiotic induction, resuspended sporulation media prior processing             regardless Ime2p wild type mutant K97R <br /> Materials Methods). 2 h postinduction, Sic1p                 (Fig. 3) (unpublished results). Importantly, CAK1 strain, <br /> destruction S phase occurring, level Ime2p               catalytically inactive Ime2p-K97R-myc protein migrated increased substantially. course sporulation,               compressed doublet comprised bands 1 2. data <br /> Ime2p migrated series electrophoretically distinct iso-          suggest slowly migrating form Ime2p (band 3) <br /> forms (Fig. 3). Recent data shown slowly              produced CAK1-dependent phosphorylation followed migrating forms Ime2p consequence phosphoryla-               autophosphorylation. data Cak1p cause <br /> tion Ime2p (1). previously shown cells lacking           modification Ime2p catalytically inactive mutant Ime2p. <br /> CAK1 modest delay inducing transcriptional                 data raise possibility Ime2p inactive  program reduction early sporulation transcript levels.            phosphorylate itself) unless previously modified differences Ime2p levels 0 h wild-type             CAK1-dependent reaction, consistent vitro kinase <br /> cak1-&#226;&#338;&#172; cells indicative difference (27). strain       assay result Fig. 4. <br /> lacking CAK1, Ime2p levels increased substantially 0                Phosphorylation T-loop Ime2p dependent 2 h. Strikingly  Ime2p migrated single               Cak1p. 10 yeast protein kinases similar modified form time points tested (Fig. 3). data             Ime2p, 6 MAP kinases, 2 Cdks, 2 glycogen <br /> indicate modification Ime2p requires Cak1p.              synthase kinases (13). family enzymes referred S-phase defect mutant cak1-&#226;&#338;&#172;/cak1-&#226;&#338;&#172; cells            CMGC (cyclin/MAPK/glycogen synthase/cyclin-like ki- failure make Ime2p inadequate <br /> posttranslational modification Ime2p. <br />    wanted test CAK1-dependent modification Ime2p correlated catalytic activity Ime2p. <br /> Ime2p previously shown phosphorylate itself Ndt80p transcription factor vitro (1, 34). Using reactions, compared catalytic activity Ime2p purified cells containing lacking CAK1. Ime2p immunopuri- <br /> fied wild-type cells phosphorylated itself Ndt80p <br /> (Fig. 4). contrast, Ime2p immunopurified cak1-&#226;&#338;&#172;/ <br /> cak1-&#226;&#338;&#172; cells unable phosphorylate itself Ndt80p                                                                             FIG. 4. Cak1p required catalytic activity Ime2p. time point tested. observations demonstrate               Epitope-tagged Ime2p immunoprecipitated (IP) sporulating <br /> Cak1p required activate Ime2p.                                     CAK1 (KSY137) cak1-&#226;&#338;&#172; (KSY138) diploid cells CDC28- <br />    Cak1p required phosphorylation Ime2p.            43244 background indicated times. Protein kinase activity characterize role Cak1p activating Ime2p, moni-             measured incubation Ime2p-myc purified MBP-Ndt80p sub- <br />                                                                          strate [&#226;&#65533;&#165;-32P]ATP. *P-Ime2 *P-Ndt80 correspond Ime2p <br /> tored electrophoretic mobility wild-type Ime2p-myc            autophosphorylation phosphorylation Ndt80p, respectively. Im- <br /> catalytically inactive Ime2p-K97R-myc wild-type                munoblot analysis shows comparable levels Ime2p-myc cak1-&#226;&#338;&#172;/cak1-&#226;&#338;&#172; mutant cells. experiments, par-               present reaction mixtures. <br />  8724     SCHINDLER ET AL.                                                                                                                                  MOL. CELL. BIOL. <br />  <br />  <br />                                                                                TABLE 4. Terminal phenotype cells overexpressing IME2 <br />                                                                                                   T-loop mutantsa <br />                                                                                                                                                                             Spore <br />                                                                                  IME2 allele <br />                                                                                                                                                                           formation <br />  <br />                                                                          IME2 ....................................................................................................&#226;&#171;&#185; <br />                                                                          ime2-Y241F..........................................................................................&#226;&#171;&#185; <br />                                                                          ime2-T242A .........................................................................................&#226;&#171;&#185; <br />                                                                          ime2-Y244F..........................................................................................&#226;&#171;&#186; <br />                                                                          ime2-T242A, Y244F ............................................................................&#226;&#171;&#186; <br />                                                                          ime2-S246A..........................................................................................&#226;&#171;&#185; <br />    FIG. 5. Cak1p required phosphorylation Ime2p. cat-                                                                                     Mutant ime2 alleles introduced high-copy-number plasmids alytically inactive ime2-K97R allele tagged myc epitope     ime2-&#226;&#338;&#172;/ime2-&#226;&#338;&#172; strain. Spore formation examined 48 h sporulation <br /> introduced CDC28-43244 background diploid cells       medium. <br /> containing (KSY189) lacking CAK1 (KSY190). Cells sporu- <br /> lated 2 h prior lysis partial purification Ime2p ion- <br /> exchange chromatography. Differences electrophoretic mobili- <br /> ties Ime2p detected immunoblot analysis anti-myc      ated meiotic S phase later Y244F mutant, antibody.                                                                17% cells completed meiosis. mutant                                                                          deficient Sic1p degradation (data shown). Similar                                                                          Y244F mutant, double mutant failed form spores. <br /> nase) family. CMGC kinases activated phosphor-                ime2-T242A, Y244F/ime2-T242A, Y244F strain exhib- <br /> ylation residues T-loops. MAPKs activated             ited meiotic defects cak1-&#226;&#338;&#172;/cak1-&#226;&#338;&#172; strain. <br /> dual phosphorylation T-loop TXY motif located 10 resi-              results suggest T242 Y244 function dues upstream catalytic APE motif subdomain VIII            Ime2p T-loop phospho-acceptors phosphorylation stim- <br /> upstream dual-specificity MAPK kinases. IME2 contains                  ulates Ime2p activity, similar regulation MAPKs. <br /> TAY aligns TXY MAPKs starts residue                 tested T-loop mutant alleles IME2 242. T242 aligns T CDC28p  Kin28p            wild-type CDC28 background. Similar phenotypes Bur1p), known sites Cak1p activating phos-              CDC28-43244 background, single Y244F <br /> phorylation.                                                             mutant partially impaired completing landmark <br />    investigate phosphorylation residues T-loop        events double mutant defective.  <br /> Ime2p needed Ime2p activity, changed codons                 ime2-Y244F ime2-T242A, Y244F substitutions <br /> encoding T Y TAY motif nearby             showed slightly severe defects CDC28-43244  <br /> phosphorylatable <span id='am-42' about='obo:IMR_0001695' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001'><span id='am-43' property="rdfs:label" content="amino acid" datatype="xsd:string"></span><span id='am-44' property="oboInOwl:hasDbXref" content="CHEBI:33709" datatype="xsd:string"></span><span id='am-45' property="oboInOwl:id" content="IMR:0001695" datatype="xsd:string"></span><span id='am-46' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-47' property="oboInOwl:hasDbXref" content="MeSH:D000596" datatype="xsd:string"></span><span id='am-48' property="obo:IAO_0000115" content="Organic compounds that generally contain an amino (-NH2) and a carboxyl (-COOH) group. Twenty alpha-amino acids are the subunits which are polymerized to form proteins." datatype="xsd:string"></span>amino acid</span> codons (S/T/Y) predicted              ground wild-type CDC28 background. example, <br /> activation loop IME2 encode nonphosphorylatable amino              double ime2-T242A, Y244F/ime2-T242A, Y244F mutant al- <br /> acids. High-copy-number plasmids containing mutant ime2 al-              lowed completion meiotic divisions 35% CDC28/ <br /> leles tested abilities complement sporu-           CDC28 cells 12% CDC28-43244 cells. lation defect ime2-&#226;&#338;&#172;/ime2-&#226;&#338;&#172; mutant. previously               CDC28-43244 genetic background, spores formed ported, ime2-T242A mutant completed meiosis formed                CDC28 cells doubly mutant ime2-T242A, Y244F.  <br /> spores wild-type levels (Table 4),  did slightly        fluence CDC28 abilities ime2 mutants slowly wild-type control (data shown).              complete S phase nuclear divisions consistent contrast, ime2-Y244F mutant completed low levels mei-             Cdc28p Ime2p functioning pathway pro- <br /> osis slowly wild-type control formed             mote events (1). <br /> spores (Table 4). Mutation T242 Y244 resulted                evidence shows clearly T242 Y244 impor- severe meiotic phenotype observed. ime2               tant Ime2p function vivo. examined CAK1-depen- <br /> T-loop mutants tested behaved indistinguishably wild            dent changes electrophoretic mobility mutant Ime2p <br /> type.                                                                    proteins isolated sporulating cells. Wild-type Ime2p-myc <br />    order assess phenotypes ime2-T242A               exhibited significant shift mobility presence CAK1 <br /> Y244F single double mutants  replaced              compared absence (Fig. 6B,  Fig. 3 5]). wild-type IME2 coding sequences mutant sequences             Importantly, double-mutant Ime2p-T242A, Y244F-myc CDC28-43244 diploid. assayed abilities            protein migrated single band, mobility indis- <br /> ime2 mutants undergo S phase, complete nuclear divi-              tinguishable cells containing lacking CAK1. effect sions, form spores. high-copy-number plasmid               single substitutions CAK1-dependent electro- <br /> assay, ime2-T242A mutant exhibited wild-type levels               phoretic mobility shift similar effect double <br /> meiosis sporulation, initiation completion S          substitution. consistently observed minor difference phase delayed 3 h, delaying completion sub-              mobility single T-loop mutant proteins wild- <br /> sequent events (Fig. 6A Table 5). ime2-Y244F mutant              type cak1-&#226;&#338;&#172; strains.  differences severe defects. background, initiation S             limits resolution electrophoretic systems tested. phase delayed 9 h, subset cells               data indicate threonine tyrosine required accumulated 4C DNA content 48 h. half               modification Ime2p seen wild-type cells suggest <br /> Y244F cells completed nuclear divisions, formed             residues modified CAK1-dependent manner. <br /> normal spores. double-mutant ime2-T242A, Y244F strain                   mutation T-loop residues reduced vivo defective single mutants. cells initi-           activity Ime2p, asked altered catalytic <br />  VOL. 23, 2003                                                                                                           CAK1 IME2              8725 <br />  <br />                                                                                TABLE 5. Meiotic phenotypes IME2 T-loop mutantsa <br />                                                                                                                                                 Spore <br />                                                                                          Strain                           % Meiosis <br />                                                                                                                                               formation <br />  <br />                                                                          IME2 CDC28-43244                                  85 &#226;&#171;&#190; 1                 &#226;&#171;&#185; <br />                                                                          ime2-T242A CDC28-43244                            86 &#226;&#171;&#190; 3                 &#226;&#171;&#185; <br />                                                                          ime2-Y244F CDC28-43244                            53 &#226;&#171;&#190; 6                 &#226;&#171;&#186; <br />                                                                          ime2-T242A, Y244F CDC28-43244                     17 &#226;&#171;&#190; 1                 &#226;&#171;&#186; <br />                                                                                                                                                           wild-type IME2 chromosomal locus replaced mutant ime2 <br />                                                                          alleles, indicated homozygous diploid strains generated. Cells                                                                          assayed 48 h sporulation medium. completion meiotic <br />                                                                          division formation spores scored described Materials                                                                          Methods. <br />  <br />  <br />  <br />                                                                          activity kinase. mixed various immunopurified <br />                                                                          epitope-tagged Ime2 proteins isolated 2-h sporulating <br />                                                                          cultures purified Ndt80p radiolabeled ATP.                                                                          shown Fig. 4, wild-type Ime2p-myc autocatalytic activity <br />                                                                          phosphorylated Ndt80p (Fig. 6C). contrast, Ime2p- <br />                                                                          T242A, Y244F-myc did phosphotransferase activity                                                                          vitro. Ime2p-T242-myc protein behaved like double <br />                                                                          mutant vitro. Surprisingly, mutation Y244 F abolished <br />                                                                          ability Ime2p phosphorylate Ndt80p vitro <br />                                                                          conditions tested, partially reduced Ime2p&#226;&#8364;&#8482;s ability                                                                          phosphorylate itself. vitro data raise possibility <br />                                                                          phosphorylation T Y Ime2p&#226;&#8364;&#8482;s T-loop resi- <br />                                                                          dues plays unique roles regulating activity enzyme. <br />                                                                             data demonstrated Cak1p functions                                                                          CDC28-independent manner activate Ime2p early sporu- <br />                                                                          lation. previously shown Cak1p functions later                                                                          pathway promote spore formation activa- <br />                                                                          tion SMK1 MAPK pathway (27). Cak1p                                                                          multiple CDC28-independent functions meiosis, Cak1p <br />                                                                          modulate phosphorylation Cdc28p meio- <br />                                                                          sis. examine CAK1-dependent phosphorylation                                                                          Cdc28p changes sporulation, probed immunoblot <br />                                                                          sporulation time course phospho-specific anti- <br />                                                                          body T169 Cdc28p. Just Ross et al. shown <br />                                                                          phosphorylation regulated mitotic cells (26), <br />                                                                          phosphorylation Cdc28p T169 uniform <br />                                                                          meiosis (Fig. 7). data suggest phos- <br />                                                                          phorylation Cdc28p Cak1p meiosis constitutive                                                                          subject regulatory control. <br />  <br />                                                                                                        DISCUSSION <br />                                                                            mitosis, Cak1p&#226;&#8364;&#8482;s essential role activate Cdc28p. <br />                                                                          meiosis, Cak1p required Cdc28p-independent <br />  <br />  <br />  <br />                                                                          (&#226;&#338;&#172;; left right: KSY138, KSY223, KSY219, KSY218). <br />    FIG. 6. Ime2p T-loop residues T242 Y244 required          cell lysates sporulating cells prepared 4 h timely S phase.   progression meiotic S phase diploid   probed antibody myc epitope. pair represents <br /> strains harboring IME2 T-loop point mutations  left right:       clearly resolved image obtained, Cak1p-depen- <br /> KSY221, KSY222, KSY220) monitored flow cytometry.             dent modification single mutants resulted small, repro- <br /> Sporulating cells fixed indicated times, nuclear DNA     ducible, change electrophoretic mobility. (C) protein kinase stained propidium iodide detect 2C 4C populations.    activity epitope-tagged Ime2p-myc mutants assayed mixing wild type (WT), 50% cells complete S phase 3 h      immunopurified Ime2p-myc purified Ndt80p (upper panel). *P- <br /> Fig. 2B wild-type control). (B) Analysis electrophoretic      Ime2 *P-Ndt80 correspond Ime2p autophosphorylation mobilities IME2 T-loop mutants conducted comparing         phosphorylation Ndt80p, respectively. relative amounts pro- epitope-tagged proteins diploids containing CAK1 (W; left    tein used reaction mixtures shown lower panel right: KSY137, KSY221, KSY222, KSY220) lacking CAK1           Western blot analysis immunoprecipitated material. <br />  8726     SCHINDLER ET AL.                                                                                                    MOL. CELL. BIOL. <br />  <br />  <br />  <br />  <br />   FIG. 7. Cdc28p-T169 phosphorylation levels change sporulation. cell lysates taken sporulating wild-type (WT) <br /> cells (LNY3) indicated times probed antibody Cdc28p (upper panel) phosphospecific antibody recog- <br /> nizing T169 phosphorylated form Cdc28p (lower panel). Strains <br /> containing lacking CAK1 CDC28-43244 genetic background <br /> (JLY3 JLY4, respectively) used controls.                      FIG. 8. Model Cak1p&#226;&#8364;&#8482;s roles meiosis. Cak1p functions <br />                                                                         Ime2p regulate S phase Sic1p destruction                                                                         Smk1p regulate spore formation. Cak1p required activate <br />                                                                         Cdc28p initiate meiotic S phase execute meiotic divisions. <br /> fashion multiple steps. previously shown                shown Cak1p activation Ime2p promotes middle <br /> Cak1p required prior induction S phase,        gene induction, M phase spore formation, inducing later step occurs spore wall assembly            expression CLBs SMK1, respectively. Genes directly regulated <br /> quired activate Smk1p MAPK (27).                    transcriptional program sporulation underlined. X                                                                         Ime2p Smk1p pathways unique shared shown Cak1p functions early meiosis promote DNA              represent Cak1p-activated kinases noncatalytic regulatory compo- <br /> synthesis sporulation-specific Ime2p protein ki-            nents promote direct phosphorylation Ime2p Smk1p nase.                                                                   Cak1p. <br />    regulation S-phase inhibitor Sic1p different meiosis mitosis. mitosis, Cdc28p complexed G1 cyclins required phosphorylate Sic1p, targeting         Ime2p meiosis-specific kinase regulated proteolysis (28). G1 cyclins inhibit meiotic induction          transcriptional program sporulation induced. present meiotic cells (4). Dirick et al.              data suggest Cak1p required phosphorylation <br /> proposed Ime2p kinase responsible targeting             T242 Y244 Ime2p&#226;&#8364;&#8482;s activation loop phos- <br /> Sic1p proteolysis meiotic cells (6). Consistent        phorylation residues necessary catalytic <br /> proposal, Cdc28p dispensable Sic1p degradation mei-           activity vivo. CAK1-dependent modification Ime2p <br /> osis (1). Sic1p protein destroyed               occur possible mechanisms. instance, <br /> schedule cak1-&#226;&#338;&#172;/cak1-&#226;&#338;&#172; cells transferred sporula-           Cak1p directly phosphorylate Ime2p, activate tion media. Ime2p failed modified activation loop          protein kinase turn required activate Ime2p. catalytically inactive cells lacking Cak1p.         laboratory unable detect phosphorylation deletion SIC1 overproduction IME2                purified Ime2p purified Cak1p vitro (27). possible, <br /> partially suppressed meiotic S-phase defect mutant                noncatalytic component missing cak1-&#226;&#338;&#172; cells. results indicate Cak1p required early       reactions. worth noting dominant activating meiosis promote activation Ime2p, turn            residue Ime2p vivo appears Y244, located stimulates meiotic S phase targeting Sic1p destruction           T-loop. Cak1p shown phosphorylate <br />  model Fig. 8). Ime2p positively regulates          threonines located 10 residues amino terminal APE <br /> transcription early sporulation genes required            motif subdomain VIII yeast Cdks, group reported <br /> timely induction middle sporulation genes.  deficit        proteomics study Cak1p-GST fusion protein Ime2p activity cells lacking CAK1 sufficient explain      phosphorylate tyrosine residues synthetic <span id='am-1' about='obo:IMR_0001700' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001'><span id='am-2' property="obo:IAO_0000115" content="The polypeptide that is not a gene product." datatype="xsd:string"></span><span id='am-3' property="oboInOwl:id" content="IMR:0001700" datatype="xsd:string"></span><span id='am-4' property="rdfs:label" content="peptide" datatype="xsd:string"></span><span id='am-5' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span>peptide</span> (42). defects transcriptional program previously           possible Cak1p activates Cdk, turn documented cak1-&#226;&#338;&#172;/cak1-&#226;&#338;&#172; background (27). role               required Ime2p activation. ruled Cdc28p Ime2p positively regulating early gene expression          uniquely required allele CDC28 used reason partial bypass S-phase defect          study lacks Cak1p-activatable threonine T-loop. observed Sic1p depleted. Alternatively,           Bur1p Kin28p Cdks shown phosphory- <br /> low levels Sic1p experiments  level            lated Cak1p T-loops (17, 41). Ctk1p Cdk detection immunoblots) partially inhibit                shown phosphorylated activation loop thre- <br /> Cdc28p-Clb5p/Clb6p S-phase-promoting ability.                   onine proteomics study (8). tested mutant alleles <br /> shown Ime2p cak1-&#226;&#338;&#172; cells catalytically inactive         BUR1, CTK1, KIN28 encode alanine substitu- <br /> vitro. ability overexpressed IME2 partially suppress          tion activating threonine T-loops. Diploid S-phase defect mutant suggests non-         strains homozygous mutant Cdks complete meiotic S <br /> phosphorylatable form Ime2p low level catalytic             phase wild-type kinetics, suggesting activity vivo Ime2p positively regulate S phase       Cdks uniquely required regulate Ime2p (unpublished noncatalytic fashion. information provides glimpse             results). <br />  <br />  <br />    issues relevant studies involving           <br /> Cak1p&#226;&#8364;&#8482;s role activating Smk1p MAPK pathway               <br /> model Fig. 8). Similar analysis Ime2p,         <br /> shown Cak1p functions upstream Smk1p (27). activation loops Ime2p Smk1p contain TXY motif.                                                <br /> Dual phosphorylation T Y Smk1p appears             <br /> required catalytic activity (27). data suggest       <br />                                                                          <br /> dual phosphorylation required Ime2p activation.      common Cak1p-activated kinase reg-               <br /> ulates Ime2p Smk1p remains determined.                  <br />    addition roles activating Ime2p Smk1p,               <br /> Cak1p required activate Cdc28p meiosis                <br /> model Fig. 8). mitosis, activation Cdc28p Cak1p           <br /> appears largely unregulated, large pools             <br /> Cdc28p phosphorylated T169 present                 <br /> cell cycle (26). level phosphorylated            <br /> Cdc28p relatively constant meiosis (Fig. 7).               data suggest Cak1p-activated Cdc28p               <br /> quired meiosis (active Cdc28p required S           <br /> M phases), modification constitutive does play          <br /> direct role regulating meiotic progression.                        <br />    Based sequence homology, Ime2p classified                Cdk-like kinase, cyclin binding partner              <br /> identified <span id='am-6' about='oboInOwl:date' typeof='owl:Thing'>date</span>. Similar roles Cdks play cell          <br /> cycle, Ime2p regulates multiple steps meiosis.         steps include initiating meiotic S phase            <br /> nuclear divisions. shown Ime2p            <br /> electrophoretically resolved series distinct phospho-          <br /> forms relative abundance changes meiotic pro-           <br /> gression (1, 34). speculate sequential phosphory-            <br /> lation Ime2p represents modification pathway            <br /> critical orderly progression successful com-      <br /> pletion sporulation. modifications alter Ime2p&#226;&#8364;&#8482;s          <br /> catalytic potency, substrate specificity, protein-protein interac-   <br /> tions, cellular localization. shown muta-       <br /> tion tyrosine nonphosphorylatable phenylalanine              <br /> modestly reduces Ime2p&#226;&#8364;&#8482;s potency autophosphorylation                 dramatically reduces ability phosphorylate Ndt80p         <br /> vitro. clear Ime2p-T242A-myc behaves like                <br /> catalytically inactive protein vitro modestly af-     <br /> fected vivo. data suggest complex         <br /> interactions T Y phosphorylation events acti-             <br /> vating Ime2p kinase. Remarkably, Ime2p completely                 <br /> unmodified, late time points, cells lacking CAK1.             data suggest Cak1p-dependent modification     <br />                                                                      <br /> Ime2p&#226;&#8364;&#8482;s activation loop required subsequent phos-             <br /> phorylation events Ime2p. Catalytically inactive Ime2p ap-            <br />                                                                      <br /> pears modified Cak1p-dependent fashion ac-             <br /> tivation loop, fails modified  data      <br /> suggest Cak1p initiates Ime2p phospho-modification              <br /> pathway autophosphorylation plays essential role         progression.                                                      <br /> </body></html>